Cipher Pharmaceuticals has consistently outperformed expectations, but can it maintain its momentum in the upcoming earnings report?
Recent earnings trend
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$427.34M
P/E
10.1x
52W high
$20.56
52W low
$12.48
1W change
+4.66%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 20.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+20.9% Upside
Current Price
C$17.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
19.7%
Annualized
90-Day Vol
33.4%
Annualized
Trend (90d)
-19.2%
Annualized drift
90d Mean
C$15.94
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$16.68 | C$15.59 – C$17.85 |
| 60 trading days | C$16.31 | C$14.81 – C$17.95 |
| 90 trading days | C$15.94 | C$14.17 – C$17.92 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 2 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 4 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-11 | — | 0.2600 | — |
| 2026-03-31 | 2026-05-07 | 0.3300 | 0.2200 | +50.0% |
| 2025-12-31 | 2026-03-12 | 0.6900 | 0.2100 | +228.6% |
| 2025-09-30 | 2025-11-06 | 0.3000 | 0.1700 | +76.5% |
| 2025-06-30 | 2025-08-07 | 0.3000 | 0.2200 | +36.4% |
| 2025-03-31 | 2025-05-08 | 0.1400 | 0.1500 | -6.7% |
Advertisement
Cipher Pharmaceuticals Inc (CPH.TO) is set to release its next earnings report on August 6, 2026, after market close. Investors are keenly watching this report as the company has a strong track record of exceeding earnings estimates, having beaten expectations in each of the last four quarters. With an estimated EPS of $0.26 for the fiscal period ending June 30, 2026, the stakes are high for this Canadian pharmaceutical firm.
Investor takeaway: As Cipher approaches its earnings date, the company’s solid history of beating estimates and its recent performance may provide a favorable outlook, despite a slight downward revision in EPS consensus. Investors should closely monitor the upcoming report for insights into the company's operational health and market positioning.
Cipher Pharmaceuticals EPS Estimate: $0.26
The company has consistently delivered strong earnings, but the current consensus reflects a projected decline in EPS compared to the previous year.
Bull case
Cipher has a strong track record of exceeding earnings estimates, with a 50% surprise in the last quarter and an impressive 228.57% surprise in the quarter before that. If this trend continues, the upcoming report could show even better financial results than expected, which could drive the stock price higher.
Bear case
Despite its solid performance history, the current EPS consensus has been revised down from $0.30 to $0.24 over the last 30 days, raising concerns about the company’s ability to maintain growth. Additionally, a year-over-year EPS decline of 20.5% might indicate some underlying challenges.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
